{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:50:21Z","timestamp":1790869821009,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.eclinm.2020.100326","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T17:03:55Z","timestamp":1588525435000},"page":"100326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man study"],"prefix":"10.1016","volume":"22","author":[{"given":"Mark","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-0829","authenticated-orcid":false,"given":"Michael","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Bulluss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendyl","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Priest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Sharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Distad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Anchordoquy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2020.100326_bib0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.eclinm.2020.100326_bib0002","series-title":"Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959\u20132009","author":"Shorvon","year":"2009"},{"key":"10.1016\/j.eclinm.2020.100326_bib0003","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eclinm.2020.100326_bib0004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.seizure.2016.11.022","article-title":"Drug development for refractory epilepsy: the past 25 years and beyond","volume":"44","author":"Golyala","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.eclinm.2020.100326_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13181-017-0626-4","article-title":"The pharmacology and toxicology of third-generation anticonvulsant drugs","volume":"13","author":"LaPenna","year":"2017","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.eclinm.2020.100326_bib0006","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1528-1167.2010.02536.x","article-title":"Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy","volume":"51","author":"Fisher","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eclinm.2020.100326_bib0007","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/WNL.0000000000001334","article-title":"Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy","volume":"84","author":"Salanova","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2020.100326_bib0008","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1212\/WNL.0b013e3182302056","article-title":"RNS system in epilepsy study group. responsive cortical stimulation for the treatment of medically intractable partial epilepsy","volume":"77","author":"Morrell","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2020.100326_bib0009","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3174\/ajnr.A4362","article-title":"Current applications of MRI-Guided laser interstitial thermal therapy in the treatment of brain neoplasms and epilepsy: a radiologic and neurosurgical overview","volume":"36","author":"Medvid","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"10.1016\/j.eclinm.2020.100326_bib0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.addr.2012.04.004","article-title":"Novel methods of antiepileptic drug delivery \u2013 polymer-based implants","volume":"64","author":"Halliday","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100326_bib0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/187152709788680698","article-title":"Polymer-based drug delivery devices for neurological disorders","volume":"8","author":"Halliday","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.eclinm.2020.100326_bib0012","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2165\/00023210-200216090-00001","article-title":"Potential new methods for antiepileptic drug delivery","volume":"16","author":"Fisher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eclinm.2020.100326_bib0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","article-title":"Intracerebroventricular delivery as a safe, long-term route of drug administration","volume":"67","author":"Cohen-Pfeffer","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.eclinm.2020.100326_bib0014","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eclinm.2020.100326_bib0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eclinm.2020.100326_bib0016","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/01616412.1995.11740311","article-title":"Anticonvulsant effect of intraventricular antiepileptic drugs. experimental study","volume":"17","author":"Gonz\u00e1lez-Darder","year":"2016","journal-title":"Neurol Res"},{"key":"10.1016\/j.eclinm.2020.100326_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eplepsyres.2006.02.003","article-title":"Effect of intracerebroventricular continuous infusion of valproic acid versus single i.p. and i.c.v. injections in the amygdala kindling epilepsy model","volume":"70","author":"Serralta","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eclinm.2020.100326_bib0018","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.0013-9580.2004.451103.x","article-title":"Australian pregnancy registry of women taking antiepileptic drugs","volume":"45","author":"Vajda","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eclinm.2020.100326_bib0019","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-007-0519-3","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates","volume":"61","author":"Stapleton","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.eclinm.2020.100326_bib0020","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1248\/bpb.23.784","article-title":"Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy","volume":"23","author":"Morikawa","year":"2000","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.eclinm.2020.100326_bib0021","first-page":"582","article-title":"Low and variable presence of valproic acid in human brain","volume":"42","author":"Shen","year":"1992","journal-title":"Am Acad Neurol"},{"key":"10.1016\/j.eclinm.2020.100326_bib0022","first-page":"486","article-title":"Human-Brain, plasma, and cerebrospinal-fluid concentration of sodium valproate after 72\u00a0H of therapy","volume":"31","author":"Vajda","year":"1981","journal-title":"Am Acad Neurol"},{"key":"10.1016\/j.eclinm.2020.100326_bib0023","first-page":"625","article-title":"Methotrexate, cytosine-arabinoside, and bcnu concentration in brain after ventriculocisternal perfusion","volume":"61","author":"Blasberg","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.eclinm.2020.100326_bib0024","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0885-3924(96)00010-3","article-title":"Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines","volume":"11","author":"Krames","year":"1996","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.eclinm.2020.100326_bib0025","series-title":"Neuromodulation","first-page":"441","article-title":"The rational use of intrathecal opioid analgesics","author":"Krames","year":"2009"},{"key":"10.1016\/j.eclinm.2020.100326_bib0026","doi-asserted-by":"crossref","first-page":"e18532","DOI":"10.1200\/JCO.2018.36.15_suppl.e18532","article-title":"A retrospective review of complication rates of ommaya reservoir placement for intrathecal medication administration","volume":"36","author":"Bosse","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eclinm.2020.100326_bib0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archinte.1990.00390130145023","article-title":"Complications associated with ommaya reservoirs in patients with cancer - the Princess margaret hospital experience and a review of the literature","volume":"150","author":"Lishner","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eclinm.2020.100326_bib0028","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ner.12010","article-title":"Rate of complications among the recipients of intrathecal baclofen pump in japan: a multicenter study","volume":"16","author":"Taira","year":"2013","journal-title":"Neuromodulation"},{"key":"10.1016\/j.eclinm.2020.100326_bib0029","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sc.2008.24","article-title":"Device-related complications of long-term intrathecal drug therapy via implanted pumps","volume":"46","author":"Flueckiger","year":"2008","journal-title":"Spinal Cord"},{"key":"10.1016\/j.eclinm.2020.100326_bib0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1545968310363585","article-title":"Procedure- and Device-Related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review","volume":"24","author":"Stetkarova","year":"2010","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.eclinm.2020.100326_bib0031","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.parkreldis.2017.09.011","article-title":"The clinical features and functional impact of valproate-induced tremor","volume":"44","author":"Alonso-Juarez","year":"2017","journal-title":"Parkins Relat Disord"},{"key":"10.1016\/j.eclinm.2020.100326_bib0032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.04.003","article-title":"Risk of valproic acid-related alopecia: a systematic review and meta analysis","volume":"69","author":"Wang","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.eclinm.2020.100326_bib0033","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1467-789X.2010.00800.x","article-title":"Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications","volume":"12","author":"Verrotti","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.eclinm.2020.100326_bib0034","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1528-1157.1976.tb04459.x","article-title":"Valproic acid - reversibly acting drug","volume":"17","author":"Lockard","year":"1976","journal-title":"Epilepsia"},{"key":"10.1016\/j.eclinm.2020.100326_bib0035","first-page":"826","article-title":"Brain binding of anticonvulsants - Carbamazepine and valproic acid","volume":"30","author":"Goldberg","year":"1980","journal-title":"Am. Acad. Neurol."}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020300705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020300705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:01:10Z","timestamp":1762887670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537020300705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":35,"alternative-id":["S2589537020300705"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100326","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man study","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100326"}}